4.2 Article

Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study

Related references

Note: Only part of the references are listed.
Article Oncology

METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER

Trang H. La et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)

Article Radiology, Nuclear Medicine & Medical Imaging

Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer

Talakad Goolaiah Lohith et al.

JOURNAL OF NUCLEAR MEDICINE (2009)

Review Oncology

Head and neck cancer: past, present and future

David Chin et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2006)

Review Oncology

Radiotherapeutic management of locally advanced head and neck cancer

S. Ghosh Laskar et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2006)

Article Oncology

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose

AS Allal et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM

F Dehdashti et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)

Article Oncology

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy

KSC Chao et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of 62Cu labeled diacetyl-bis(N4-methoylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer

N Takahashi et al.

ANNALS OF NUCLEAR MEDICINE (2000)